Drug intelligence / Profile preview

Gardner's Miracle Bath Salts

Development stage: Preclinical
Lead developer: InventHelp
Modality: Small Molecules
Administration: Topical

Overview

Gardner's Miracle Bath Salts is a therapeutic topical product developed through InventHelp that utilizes cannabis as its primary active ingredient. The formula is specifically designed to alleviate chronic pain and muscle soreness by allowing the therapeutic benefits of cannabis to be absorbed externally through a bath soak, rather than through internal consumption. This product is intended for individuals seeking alternative relief for physical discomfort and is explicitly distinguished from synthetic 'bath salts' (cathinones), which are illicit stimulants.

Brand names: Gardner's Miracle Bath Salts

Targets

CNR1 (Cannabinoid receptor 1)

Beyond the preview

Go deeper on Gardner's Miracle Bath Salts.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Gardner's Miracle Bath Salts.

Explore the full profile